ARCH Venture Fund XIII, L.P.
10% Owner · 1 filing · Latest: Mar 6, 2026
Lyell Immunopharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LYEL | ARCH Venture Fund XIII, L.P. | 10% Owner | Mar 6, 2026 | Purchase | $25.61 | 488,090 | $12.5M | 1,426,528 |